Celldex Therapeutics Logo

Celldex Therapeutics

🇺🇸
CLDX
US15117B2025

Celldex Therapeutics is a US-based biopharmaceutical company specializing in the development of innovative antibody therapeutics. It focuses on researching targeted treatments for cancer and inflammatory diseases by leveraging advanced immunological approaches.

Next Quarterly Earnings

Wednesday, November 11, 2026
CW 46
After-Hours
In 76 days

After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

Quiet period starts on October 14, 2026

Stock Price

Frequently asked questions

When will Celldex Therapeutics report its next quarterly earnings?

Celldex Therapeutics is scheduled to report its next quarterly earnings on 11/11/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

When did Celldex Therapeutics last report quarterly earnings?

Celldex Therapeutics last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -0.94 USD.

How often has Celldex Therapeutics beaten expectations?

Celldex Therapeutics has beaten analyst EPS estimates in 1 of its last 5 evaluated quarters (beat rate: 20%).

How do I add the Celldex Therapeutics earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$1.07
Actual:
Q2 2026
Beat
Estimate:-$1.06
Actual:-$0.94
Difference:+$0.12
Q1 2026
Missed
Estimate:-$1.14
Actual:-$1.18
Difference:-$0.04
Price reaction (1 day):+2.0 %
Price reaction (7 days):-2.6 %
Q4 2025
Missed
Estimate:-$1.02
Actual:-$1.22
Difference:-$0.20
Price reaction (1 day):-0.6 %
Price reaction (7 days):-4.2 %
Q2 2025
Missed
Estimate:-$0.89
Actual:-$1.01
Difference:-$0.12
Q1 2025
Missed
Estimate:-$0.84
Actual:-$0.85
Difference:-$0.01

Earnings statistics

Estimates vs. results

1/5
Quarters above estimates
20%
Beat rate
-2.4%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Celldex Therapeutics
Ticker Symbol
CLDX
ISIN
US15117B2025
Country
🇺🇸
USA
Sector